Clinical Trials Logo

Filter by:
NCT ID: NCT02157948 Completed - Clinical trials for Postmenopausal Osteoporosis

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Start date: May 2014
Phase: Phase 3
Study type: Interventional

This study will compare the effect of denosumab produced by two different manufacturing processes on bone mineral density at the lumbar spine in postmenopausal women with osteoporosis.

NCT ID: NCT02157922 Completed - Cystic Fibrosis Clinical Trials

A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis

SMR-2984
Start date: October 2014
Phase: Phase 2
Study type: Interventional

The purpose of the study is assessment of efficacy and safety of OligoG as a dry powder formulation, in adult subjects with cystic fibrosis.

NCT ID: NCT02157350 Completed - Clinical trials for Proliferative Diabetic Retinopathy

The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT

IMPETUS-D
Start date: August 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the threshold level of proliferative diabetic retinopathy progression and regression after standard panretinal photocoagulation. Predictors of progression and regression will be identified which will include retinal vessel geometry (caliber, fractals and tortuosity), retinal vessel oxygen saturation and retinal areas of non-perfusion.

NCT ID: NCT02157155 Completed - Clinical trials for Diabetes Mellitus Type 1

A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis

Start date: June 2014
Phase: N/A
Study type: Interventional

Hypothesis 1. To define whether stimulation of ATGL and suppression of G0/G1 switch gene occur in the initial phases of diabetic ketoacidosis and thus can be identified as the primary mechanisms behind this life threatening condition. 2. Make a human model for studying ketoacidosis. The investigators plan to reduce in their regular insulin over night. In the morning we administer endotoxin, which together with a relative lack of insulin will initiate ketogenesis - a state of ketoacidosis. On another occasion strict glycemic control is imposed by means of intravenous insulin. The testing is done two separate days with at least 3 weeks in between and patients are admitted to hospital the evening before the day of testing. The investigators use isotopic tracers to determine metabolic fluxes and analyse fat (ATGL, G0/G1 switch gene) and muscle biopsies.

NCT ID: NCT02156921 Completed - Training Efficiency Clinical Trials

App-guided Training in eFAST Ultrasound

Start date: May 2014
Phase: N/A
Study type: Interventional

This study aims to investigate the cost-effectiveness of app-based self-directed ultrasound training compared to self-directed training with written handouts on subsequent performance on simulated patient cases and theoretical cases.

NCT ID: NCT02156141 Completed - Healthy Subjects Clinical Trials

High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy

HIT in Kennedy
Start date: June 2014
Phase: N/A
Study type: Interventional

We want investigate if high intensity training can increase daily functionality without causing muscle damage in patients Spinal and Bulbar Muscular Atrophy . We want to study if there is a difference in effect with supervised and unsupervised training. Furthermore we want to study if a supervised training program will motivate participants to continue training by the end of the program.

NCT ID: NCT02155907 Completed - Stroke Clinical Trials

Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA

Start date: June 1, 2013
Phase:
Study type: Observational [Patient Registry]

Purpose 1. To validate 2 -day loop recording ( R.Test Evolution 4 ) to 2 -day Holter recording (gold standard) for the detection of atrial fibrillation of ≥ 30 seconds duration in a consecutive population of patients with stroke or transient ischemic attack (TIA). 2. To determine whether short run of atrial fibrillation (< 30s ) or the presence of many supraventricular extrasystoles detected on Holter recording, is associated with risk of re-stroke in a consecutive population of patients with stroke or TIA . 3. To test whether a 7-day Loop Recording (R -test) detects more patients with atrial fibrillation than 2 days of Holter recording in a consecutive population of patients with stroke or TIA.

NCT ID: NCT02155894 Completed - Clinical trials for Rheumatoid Arthritis

Tight Control of Disease Activity Among Patients With RA Based on a Systematic Telemedicine Treatment Strategy

TeRA
Start date: May 2014
Phase: N/A
Study type: Interventional

The study aims to investigate the effect a systematic telemedicine intervention, based on the tigth control principals, as a platform for disease monitoring among patients with rheumatoid arthritis. It is hypothesized that: - A systematic telemedicine intervention targeted to tight control of disease activity among patients with RA will be equally effective as usual care (outpatient consultation by a rheumatologist). - There will be no difference in the effect whether this telemedicine consultation is carried out by a rheumatologist or a rheumatology nurse. - Patient satisfaction and the patient's general perception of involvement in their treatment will be increased for patients who receive the telemedicine intervention. - All the effects will apply both in the short term (< 6 months) and in the long term (> 1 year).

NCT ID: NCT02155660 Completed - Clinical trials for Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

TERRANOVA
Start date: June 25, 2014
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of care therapies.

NCT ID: NCT02154204 Completed - Clinical trials for Focus of Study is: Near Infrared Fluorescence Imaging

A Validation Study of Near Infrared Fluorescence Imaging of Lymphatic Vessels in Humans.

Start date: May 2014
Phase: N/A
Study type: Observational

The aim of this study is to examine the use of Near Infrared Fluorescence imaging on lymphatic vessels in humans. Different parameters that reflect lymphatic function will be tested for intra and inter individual reproducibility. We use 10 healthy test subjects and examine their lymphatic system. All subjects are healthy men between the ages of 20 and 30. When the fluorescent dye "indocyanine green", has been injected into the skin on the patients feet, it will be transported through the lymph vessels, resulting in clear visualization of the vessels, using a laser and a EM-CCD camera. On both legs we examine the frequency of vessel contraction and the velocity of lymph moving in vessels. We furthermore use several methods to quantify the vessel function such as the refill time of a vessel, (manually emptied vessel and refill time of 10 cm of a vessel), and pumping pressure (at what pressure lymph can pass a blood pressure cuff). We investigate the activity of vessels over time, and after several interventions such as exercise, and water baths of the foot at different temperatures. The patients are examined for approximately 4 hours and wil be examined again 14 days later.